The study, titled “Far-UVC (222 nm) efficiently inactivates an airborne pathogen in a room-sized chamber(link is external and opens in a new window),” was published in Scientific Reports on March 23.
The authors are Ewan Eadie (Ninewells Hospital, Dundee, Scotland), Waseem Hiwar (University of Leeds, England), Louise Fletcher (University of Leeds), Emma Tidswell (University of Leeds), Paul O’Mahoney (University of Dundee), Manuela Buonanno (Columbia University), David Welch (Columbia University), Catherine Adamson (St. Andrews University, Scotland), David Brenner (Columbia University), Catherine Noakes (University of Leeds), and Kenneth Woods (University of St. Andrews).
The study was supported by grants from the U.K. Health Security Agency.
David J. Brenner and co-inventors have been granted a U.S. patent titled “Apparatus, method and system for selectively affecting and/or killing a virus” (US1078019B2). Columbia University has licensed aspects of filtered UV light technology to USHIO Inc. Other disclosures are noted in the paper.